Form D · Biotechnology
Cardium Therapeutics, Inc.
San Diego, CA · CIK 0000772320
Offering snapshot reported Jun 23, 2009 · SEC filing
- Reported sold
- $750K Offering amount: $750K
- Investors reported
- 8 Form D · investor count
- Minimum accepted
- $10K Reported outside-investor minimum
- First sale
- Jun 11, 2009 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jun 23, 2009 | Initial | $750,000 | No comparison | 8 | SEC filing |
| Mar 18, 2009 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Nov 28, 2008 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Sep 11, 2006 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Mar 24, 2006 | Paper | Not reported | No comparison | Not reported | |
| Nov 10, 2005 | Paper | Not reported | No comparison | Not reported | SEC filing |
| May 31, 2005 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Not reported
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $18K
- Finders' fees
- $0
- Form D file number
- 021-83205
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| Empire Asset Management Company | 143007 |
Source: Form D, filed Jun 23, 2009. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Tyler M. Dylan | Director, Executive |
| Edward W. Gabrielson | Director |
| Murray H. Hutchison | Director |
| Andrew M. Leitch | Director |
| Gerald J. Lewis | Director |
| Dennis M. Mulroy | Executive |
| Lon E. Otremba | Director |
| Christopher J. Reinhard | Director, Executive |
| Ronald I. Simon | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
12255 El Camino Real Suite 250
San Diego, CA, 92130
San Diego, CA, 92130